Last 13.88 GBp
Change Today -0.62 / -4.31%
Volume 107.9K
ODX On Other Exchanges
As of 11:30 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

omega diagnostics group plc (ODX) Snapshot

14.50 GBp
Previous Close
14.50 GBp
Day High
14.50 GBp
Day Low
12.75 GBp
52 Week High
03/10/14 - 32.25 GBp
52 Week Low
02/27/15 - 12.75 GBp
Market Cap
Average Volume 10 Days
0.0058 GBp
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

omega diagnostics group plc (ODX) Related Businessweek News

No Related Businessweek News Found

omega diagnostics group plc (ODX) Details

Omega Diagnostics Group PLC, together with its subsidiaries, manufactures, develops, and distributes medical diagnostics products. The company operates in three segments: Allergy and Autoimmune, Food Intolerance, and Infectious Diseases. The Allergy and Autoimmune segment researches, develops, produces, and markets in vitro allergy and autoimmune tests that are used by doctors to diagnose patients with allergies and autoimmune diseases. This segment’s principal products include Allergozyme, Allergodip, and Genesis Elisa. The Food Intolerance segment engages in the research, development, and production of kits to aid the detection of immune reactions to food. This segment also provides clinical analysis to the general public, clinics, and health professionals, as well as supplies consumer food detective test products. Its principal products include Genarrayt microarray, Food Detective, and Foodprint service. The Infectious Diseases segment is involved in the research, development, production, and marketing of kits that are used in the diagnosis of infectious diseases. Its principal products comprise Immutrep Syphilis, Micropath Bacterial tests, and Dengue Elisa. The company offers its products to hospitals, blood banks, clinics, and laboratories through distributors and sales teams in approximately 100 countries worldwide. Omega Diagnostics Group PLC was founded in 1987 and is headquartered in Alva, the United Kingdom.

135 Employees
Last Reported Date: 07/11/14
Founded in 1987

omega diagnostics group plc (ODX) Top Compensated Officers

Founder, Chief Executive Officer, Managing Di...
Total Annual Compensation: 145.0K GBP
Group Finance Director, Company Secretary and...
Total Annual Compensation: 115.0K GBP
Group Sales & Marketing Director and Executiv...
Total Annual Compensation: 110.0K GBP
Compensation as of Fiscal Year 2014.

omega diagnostics group plc (ODX) Key Developments

Omega Diagnostics Group PLC Reports Unaudited Consolidated Earnings Results for the Six Months Ended September 30, 2014

Omega Diagnostics Group PLC reported unaudited consolidated earnings results for the six months ended September 30, 2014. Revenue was £5.7 million against £5.6 million last year. Operating profit was £0.2 million against £0.2 million last year. Profit before taxation was £0.2 million against £0.2 million last year. Profit for the period was £0.2 million against £0.2 million last year. Basic and diluted EPS was 0.2 pence against 0.3 pence last year. Adjusted profit before taxation was £0.6 million against £0.4 million last year. Adjusted basic and diluted EPS was 0.5 pence against 0.6 pence last year. Net cash flow from operating activities was £0.3 million against £0.4 million last year. Purchase of property, plant and equipment was £0.4 million against £0.3 million last year. Purchase of intangible assets was £0.6 million against £0.6 million last year. Adjusted profit attributable to equity holders of the group was £0.5 million against £0.5 million last year.

Omega Diagnostics Group plc Announces Trading Update for the First Half Ended September 30, 2014; Revised Earnings Guidance for the Full Year 2014

Omega Diagnostics Group PLC announced trading update for the first half ended September 30, 2014. Turnover is expected to be £5.69 million, slightly ahead of last year's first-half result of £5.59 million. Due to careful management of costs and an improved segmental mix of business, profit before tax (before acquisition costs, share based payments, IFRS-related discount unwinds and amortisation of intangible assets) is expected to be approximately £0.56 million, some 30% ahead of the £0.43 million earned in the previous half-year period to 30 September 2013. The management of the company expects that 2014 financial performance will be below that previously envisaged.

Omega Diagnostics Group PLC to Report First Half, 2015 Results on Nov 26, 2014

Omega Diagnostics Group PLC announced that they will report first half, 2015 results on Nov 26, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ODX:LN 13.88 GBp -0.62

ODX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ODX.
View Industry Companies

Industry Analysis


Industry Average

Valuation ODX Industry Range
Price/Earnings 24.1x
Price/Sales 1.2x
Price/Book 0.8x
Price/Cash Flow 23.0x
TEV/Sales 1.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OMEGA DIAGNOSTICS GROUP PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at